Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in Portal Vein Thrombosis After Splenectomy
NCT07461532Recruiting
- Sponsor
- Subei People's Hospital
- Start
- Apr 2026
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in portal vein thrombosis (PVT), sponsored by Subei People's Hospital. Primary endpoint: Proportion of complete recanalization of portal vein thrombosis at 6 months. Started Apr 2026; status: recruiting.
02
Drugs
apixaban
03
Conditions
portal vein thrombosis (PVT)
Beyond the preview
Go deeper on NCT07461532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07461532.